LETTER: This is the right Congress to rewrite health care laws

A Congress that favors less government regulation, less government spending and more free trade is rewriting the health care law. This is a great combination.

Other nations spend much less on health care than the United States and still rank higher than the U.S. in the health of their citizens. Therefore, reducing the cost of health services and drugs necessary for our health will reduce the cost of health insurance for all. If people receive a subsidy to purchase their insurance, it would be lowered — less government spending.

Government regulations drive up the cost of drugs. Drug companies have a 20-year monopoly on a new drug before generics can be offered. They can set their own price. It is not a free trade market. Do away with this regulation and create a free trade environment.

Drug companies claim they need to recoup R&D costs. Since drug companies have some of the highest profit margins of any U.S.-based corporation, they are very adequately compensated. They often get government dollars (subsidies) for this research. Should we change the regulation so that the companies must pay back these monies when they are marketing the drug — less government spending.

Some drugs cost much less in other countries that have a better health ranking than the U.S. For example, Humira costs $2,670 per month in the U.S., but about $900 in Switzerland. Another regulation makes it illegal to import drugs from another country. Let’s get rid of that regulation.

Certainly, less government spending and regulation, combined with better health care, should be a priority of the people we elect to represent our interests.